KBC Group
ARNA

KBC Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

KBC Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,114
Closed -$89K – 1490
2014
Q3 		$89K Hold
2,114
– – ﹤0.01% 1159
2014
Q2 		$124K Buy
2,114
+264
+14% +$16.6K ﹤0.01% 1153
2014
Q1 		$117K Buy
1,850
+793
+75% +$52.6K ﹤0.01% 1101
2013
Q4 		$62K Hold
1,057
– – ﹤0.01% 1205
2013
Q3 		$56K Hold
1,057
– – ﹤0.01% 1149
2013
Q2 		$81K Buy
+1,057
New +$86.3K ﹤0.01% 1130

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KBC Group's ARNA Position: Q4 2014 in Review

KBC Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2014, closing a stake of 2,114 shares — an estimated $89K sold.

KBC Group first reported a position in ARNA in Q2 2013 and held it in 6 quarters. The position peaked at $124K in Q2 2014. 129 funds tracked by Wall St. Rank hold ARNA as of Q4 2014.

  • KBC Group reported no remaining Arena Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • KBC Group sold 2,114 Arena Pharmaceuticals Inc shares in Q4 2014, an estimated $89K.
  • KBC Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 6 quarters.
  • KBC Group's Arena Pharmaceuticals Inc position peaked at $124K in Q2 2014.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2014.

Based on KBC Group's 13F filing for Q4 2014, filed 12 Feb 2015.